TRCT
PRCT icon

Tower Research Capital (TRC)’s Procept Biorobotics PRCT Stock Holding History

Tower Research Capital (TRC)’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.8K Sell
3,444
-538
-14% -$13.5K ﹤0.01% 2380
2026
Q1 		$99.6K Buy
3,982
+2,271
+133% +$64K ﹤0.01% 2195
2025
Q4 		$53.8K Sell
1,711
-116
-6% -$3.85K ﹤0.01% 2364
2025
Q3 		$65.2K Sell
1,827
-4,439
-71% -$203K ﹤0.01% 2319
2025
Q2 		$361K Buy
6,266
+5,492
+710% +$311K 0.01% 1264
2025
Q1 		$45.1K Sell
774
-2,002
-72% -$137K ﹤0.01% 2294
2024
Q4 		$224K Buy
2,776
+1,809
+187% +$155K ﹤0.01% 1639
2024
Q3 		$77.5K Sell
967
-5,360
-85% -$381K ﹤0.01% 2442
2024
Q2 		$387K Buy
6,327
+5,837
+1,191% +$347K 0.01% 1550
2024
Q1 		$24.2K Sell
490
-5,917
-92% -$282K ﹤0.01% 2822
2023
Q4 		$269K Buy
6,407
+4,320
+207% +$147K ﹤0.01% 1860
2023
Q3 		$68.5K Sell
2,087
-842
-29% -$28.7K ﹤0.01% 2282
2023
Q2 		$104K Buy
2,929
+2,068
+240% +$68.4K ﹤0.01% 2001
2023
Q1 		$24K Buy
861
+183
+27% +$6.46K ﹤0.01% 3250
2022
Q4 		$28K Sell
678
-1,610
-70% -$69.1K ﹤0.01% 2815
2022
Q3 		$95K Sell
2,288
-2,333
-50% -$93.1K ﹤0.01% 2607
2022
Q2 		$151K Buy
4,621
+4,533
+5,151% +$165K ﹤0.01% 1992
2022
Q1 		$3K Sell
88
-1,099
-93% -$26.4K ﹤0.01% 5400
2021
Q4 		$30K Buy
+1,187
New +$43.9K ﹤0.01% 3227

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tower Research Capital (TRC)'s PRCT Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Procept Biorobotics (PRCT) stake by 14% in Q2 2026, selling an estimated $13.5K and leaving 3,444 shares worth $77.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2380.

Tower Research Capital (TRC) first reported a position in PRCT in Q4 2021 and has held it in 19 quarters since. The position peaked at $387K in Q2 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Tower Research Capital (TRC) held 3,444 shares of Procept Biorobotics worth $77.8K as of Q2 2026.
  • Tower Research Capital (TRC) sold 538 Procept Biorobotics shares in Q2 2026, an estimated $13.5K.
  • Procept Biorobotics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2380 holding.
  • Tower Research Capital (TRC) first reported a position in Procept Biorobotics in Q4 2021 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s Procept Biorobotics position peaked at $387K in Q2 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.